Progression-free survival rate as primary end point for phase II cancer clinical trials: application to mesothelioma--The EORTC Lung Cancer Group
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Richard J. Sylvester |
| Publication date | July 1, 2006 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |